LEUCOMETHYLENE BLUE (is an active metabolite) 
| LEUCOMETHYLENE BLUE | ATC V03AB17 ATC V04CG05
TREATMENT OF METHEMOGLOBINEMIA AN OXIDATION-REDUCTION AGENT PROMOTES A NON-ENYZMATIC REDOX CONVERSION OF METHB TO HEMOGLOBIN CONVERTED INTO LEUCOMETHYLENE BLUE (LMB) BY NADPH REDUCTASE | - | | HEMOGLOBIN IRON | More at DrugCentral | ANSM (in French) Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |